Abstract
Alzheimer’s disease (AD) is a clinically, anatomically and biologically heterogeneous disorder encompassing a wide spectrum of cognitive profiles, ranging from the typical amnestic syndrome to visuospatial changes in posterior cortical atrophy, language deficits in primary progressive aphasia and behavioural/executive dysfunctions in anterior variants. With the emergence of functional imaging and neural network analysis using graph theory for instance, some authors have hypothesized that this phenotypic variability is produced by the differential involvement of large-scale neural networks – a model called ‘molecular nexopathy’. At the moment, however, the hypothesized mechanisms underlying AD’s divergent network degeneration remain speculative and mostly involve selective premorbid network vulnerability. Herein we present an overview of AD’s clinicoanatomical variability, outline functional imaging and graph theory contributions to our understanding of the disease and discuss ongoing debates regarding the biological roots of its heterogeneity. We finally discuss the clinical promises of statistical signal processing disciplines (graph theory and information theory) in predicting the trajectory of AD variants. This paper aims to raise awareness about AD clinicoanatomical heterogeneity and outline how statistical signal processing methods could lead to a better understanding, diagnosis and treatment of AD variants in the future.
Keywords: Alzheimer’s disease, frontal AD, functional connectivity, heterogeneity, logopenic aphasia, posterior cortical atrophy, selective network vulnerability.
Current Alzheimer Research
Title:Untangling Alzheimer’s Disease Clinicoanatomical Heterogeneity Through Selective Network Vulnerability – An Effort to Understand a Complex Disease
Volume: 13 Issue: 5
Author(s): David Bergeron, Reda Bensaïdane and Robert Laforce
Affiliation:
Keywords: Alzheimer’s disease, frontal AD, functional connectivity, heterogeneity, logopenic aphasia, posterior cortical atrophy, selective network vulnerability.
Abstract: Alzheimer’s disease (AD) is a clinically, anatomically and biologically heterogeneous disorder encompassing a wide spectrum of cognitive profiles, ranging from the typical amnestic syndrome to visuospatial changes in posterior cortical atrophy, language deficits in primary progressive aphasia and behavioural/executive dysfunctions in anterior variants. With the emergence of functional imaging and neural network analysis using graph theory for instance, some authors have hypothesized that this phenotypic variability is produced by the differential involvement of large-scale neural networks – a model called ‘molecular nexopathy’. At the moment, however, the hypothesized mechanisms underlying AD’s divergent network degeneration remain speculative and mostly involve selective premorbid network vulnerability. Herein we present an overview of AD’s clinicoanatomical variability, outline functional imaging and graph theory contributions to our understanding of the disease and discuss ongoing debates regarding the biological roots of its heterogeneity. We finally discuss the clinical promises of statistical signal processing disciplines (graph theory and information theory) in predicting the trajectory of AD variants. This paper aims to raise awareness about AD clinicoanatomical heterogeneity and outline how statistical signal processing methods could lead to a better understanding, diagnosis and treatment of AD variants in the future.
Export Options
About this article
Cite this article as:
Bergeron David, Bensaïdane Reda and Laforce Robert, Untangling Alzheimer’s Disease Clinicoanatomical Heterogeneity Through Selective Network Vulnerability – An Effort to Understand a Complex Disease, Current Alzheimer Research 2016; 13 (5) . https://dx.doi.org/10.2174/1567205013666151116125155
DOI https://dx.doi.org/10.2174/1567205013666151116125155 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
Early nutritional intervention and physical activity in the prevention of Alzheimer's disease and other dementias
The aim is to broaden the knowledge about the impact of the consumption of food ingredients, diet ingredients, methods of processing of food raw materials as well as the impact of composing of diets on the possibility of preventing Alzheimer's disease and other types of dementia at each stage of ...read more
Enhancing Alzheimer's Disease Diagnosis and Treatment Efficacy Prediction with Explainable AI, Radiomics, Biomarkers, and Multimodal Neuroimaging
The thematic issue, Enhancing Alzheimer's Disease Diagnosis and Treatment Efficacy Prediction with Explainable AI, Radiomics, Biomarkers, and Multimodal Neuroimaging, aims to bridge the gap between advanced computational techniques and clinical practice in Alzheimer’s disease research. Alzheimer’s disease poses significant challenges in early diagnosis, disease progression monitoring, and predicting treatment efficacy. ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
γ-Secretase as a Therapeutic Target for the Treatment of Alzheimers Disease
Current Pharmaceutical Design A Review on Rotenoids: Purification, Characterization and its Biological Applications
Mini-Reviews in Medicinal Chemistry <i>In Vivo/Ex Vivo</i> EPR Investigation of the Brain Redox Status and Blood-Brain Barrier Integrity in the 5xFAD Mouse Model of Alzheimer's Disease
Current Alzheimer Research Physalin B Reduces Tau Phosphorylation and Cell Apoptosis in HEK293 Cells by Activating FoxO1
Current Molecular Pharmacology AMPK: Potential Therapeutic Target for Alzheimer's Disease
Current Protein & Peptide Science Body-centred and Object-centred Motor Imagery in Alzheimer's Disease
Current Alzheimer Research The Use of Stem Cells in Regenerative Medicine for Parkinson’s and Huntington’s Diseases
Current Medicinal Chemistry Loss of Medial Septum Cholinergic Neurons in THY-Tau22 Mouse Model: What Links with tau Pathology?
Current Alzheimer Research The Cholinergic Potential, the Vagus Nerve and Challenges in Treatment of Traumatic Brain Injury
Current Pharmaceutical Design Depression and Anxiety Levels Increase Chronic Musculoskeletal Pain in Patients with Alzheimer's Disease
Current Alzheimer Research Differential Cued-Stroop Performance in Cognitively Asymptomatic Older Adults with Biomarker-Identified Risk for Alzheimer’s Disease: A Pilot Study
Current Alzheimer Research Vascular Effects of Estrogenic Menopausal Hormone Therapy
Reviews on Recent Clinical Trials Beneficial Actions of Polyunsaturated Fatty Acids in Cardiovascular Diseases: But, How and Why?
Current Nutrition & Food Science Synthesis, Characterisation and Docking Studies of Thioxoquinoline Derivatives as Potential Anti-Alzheimer Agents
Current Drug Discovery Technologies Recent Advances in the Applications of SAMP/RAMP as Chiral Auxiliaries in Asymmetric Synthesis
Current Organic Synthesis A Computational Study of Natural Compounds from Bacopa monnieri in the Treatment of Alzheimer's Disease
Current Pharmaceutical Design Usefulness of CSF Biomarkers in Predicting the Progression of Amnesic and Nonamnesic Mild Cognitive Impairment to Alzheimer’s Disease
Current Aging Science Patents of Pentoxifylline Administration on Some Diseases and Chronic Wounds
Recent Patents on Regenerative Medicine A Rationale for Curcuminoids for the Prevention or Treatment of Alzheimers Disease
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents APP Transgenic Mouse Models and their Use in Drug Discovery to Evaluate Amyloid-β Lowering Therapeutics
CNS & Neurological Disorders - Drug Targets